ATE382099T1 - Nachweis von invasivem krebs induziert von hpv und dessen vorläufer läsionen mit invasionspotential - Google Patents

Nachweis von invasivem krebs induziert von hpv und dessen vorläufer läsionen mit invasionspotential

Info

Publication number
ATE382099T1
ATE382099T1 AT03075928T AT03075928T ATE382099T1 AT E382099 T1 ATE382099 T1 AT E382099T1 AT 03075928 T AT03075928 T AT 03075928T AT 03075928 T AT03075928 T AT 03075928T AT E382099 T1 ATE382099 T1 AT E382099T1
Authority
AT
Austria
Prior art keywords
tslc1
hpv
invasive
precursor lesions
detection
Prior art date
Application number
AT03075928T
Other languages
English (en)
Inventor
Christophorus Meijer
Petrus Snijders
Renske Steenbergen
Original Assignee
Stichting Res Fonds Pathologie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Res Fonds Pathologie filed Critical Stichting Res Fonds Pathologie
Application granted granted Critical
Publication of ATE382099T1 publication Critical patent/ATE382099T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
AT03075928T 2003-03-31 2003-03-31 Nachweis von invasivem krebs induziert von hpv und dessen vorläufer läsionen mit invasionspotential ATE382099T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03075928A EP1464709B1 (de) 2003-03-31 2003-03-31 Nachweis von invasivem Krebs induziert von HPV und dessen Vorläufer Läsionen mit Invasionspotential

Publications (1)

Publication Number Publication Date
ATE382099T1 true ATE382099T1 (de) 2008-01-15

Family

ID=32842793

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03075928T ATE382099T1 (de) 2003-03-31 2003-03-31 Nachweis von invasivem krebs induziert von hpv und dessen vorläufer läsionen mit invasionspotential

Country Status (6)

Country Link
US (2) US7501261B2 (de)
EP (1) EP1464709B1 (de)
AT (1) ATE382099T1 (de)
DE (1) DE60318294T2 (de)
ES (1) ES2298467T3 (de)
WO (1) WO2004087962A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070122909A1 (en) * 2003-10-20 2007-05-31 Syssmex Corporation Method of treating cells
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
JP5131946B2 (ja) * 2005-09-13 2013-01-30 国立大学法人 東京大学 がんの診断、処置および／または予防、および／または浸潤・転移の抑制のための方法、システムおよび組成物ならびに関連するスクリーニング方法
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
ES2625259T3 (es) 2006-08-29 2017-07-19 Oxford Biotherapeutics Ltd Identificación de proteína asociada con carcinoma hepatocelular, glioblastoma y cáncer de pulmón
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US20100003704A1 (en) * 2008-06-13 2010-01-07 Shuling Cheng IN SITU detection of early stages and late stages HPV infection
US20100316990A1 (en) * 2008-01-16 2010-12-16 Medical College Of Georgia Research Institute, Inc Georgia Biomarkers for HPV-Induced Cancer
PT2283154E (pt) * 2008-04-14 2013-08-29 Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg Diagnóstico molecular para cancros cervicais invasivos induzidos por hpv e as suas lesões precursoras de alto grau
BRPI1009232B1 (pt) * 2009-03-05 2022-05-03 E.R. Squibb & Sons, Llc. Anticorpo monoclonal isolado ou uma porção de ligação de antígeno do mesmo, ou um fragmento de anticorpo, composição que os compreende, molécula de ácido nucleico, hibridoma e métodos para a preparação de um anticorpo anti-cadm1
JP2012526286A (ja) 2009-05-07 2012-10-25 オンコヘルス コーポレーション ヒトパピローマウイルス（ｈｐｖ）およびｈｐｖ関連癌の初期段階および後期段階の検出、スクリーニング、および診断のための高度または≧ｃｉｎ２の同定
WO2011036173A1 (en) * 2009-09-24 2011-03-31 Oncomethylome Sciences S.A. Detection and prognosis of cervical cancer
CN102822672B (zh) 2010-01-08 2015-12-09 安科健康公司 用于诊断和筛选与hpv有关的癌症的高通量细胞基hpv免疫测定
EP2548025A4 (de) 2010-03-17 2013-09-25 Univ Michigan Verwendung von phagenepitopen zur profilierung einer immunreaktion
WO2011120015A2 (en) * 2010-03-26 2011-09-29 Armune Biosciences, Inc. Method and system of particle-coupled phage epitope
WO2013130517A1 (en) * 2012-02-27 2013-09-06 The Johns Hopkins University Dna hypermethylation of promoters of target genes and clinical diagnosis and treatment of hpv related disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19729697C1 (de) 1997-07-11 1999-02-11 Mannesmann Vdo Ag Anordnung zum Bestimmen der relativen Luftfeuchte
ES2246546T3 (es) * 1997-12-12 2006-02-16 Digene Corporation Valoracion de enfermedades relacionadas con el virus de papiloma humano.
CA2419529C (en) 2000-08-15 2013-02-12 The John Hopkins University School Of Medicine Diagnosis and treatment of tumor-suppressor associated disorders

Also Published As

Publication number Publication date
DE60318294T2 (de) 2008-12-11
US20060252029A1 (en) 2006-11-09
EP1464709A1 (de) 2004-10-06
WO2004087962A1 (en) 2004-10-14
DE60318294D1 (de) 2008-02-07
US7501261B2 (en) 2009-03-10
EP1464709B1 (de) 2007-12-26
US20090203072A1 (en) 2009-08-13
ES2298467T3 (es) 2008-05-16

Similar Documents

Publication Publication Date Title
ATE382099T1 (de) Nachweis von invasivem krebs induziert von hpv und dessen vorläufer läsionen mit invasionspotential
Struys et al. Serum sarcosine is not a marker for prostate cancer
Nazarian et al. Atypical and malignant hidradenomas: a histological and immunohistochemical study
WO2008107134A3 (en) A method for detection of liver cancer, risk of liver cancer, risk of recurrence of liver cancer, malignancy of liver cancer and progression of liver cancer with time by using the methylated cytosine in basp1 gene and/or srd5a2 gene
WO2006008128A3 (en) Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders
WO2005072049A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis
Kim et al. Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women
WO1998010069A3 (en) E25a protein, methods for production and use thereof
WO2007146668A3 (en) Use of imp3 as a prognostic marker for cancer
Liu et al. Application of carbon nanoparticles in tracing lymph nodes and locating tumors in colorectal cancer: a concise review
NZ588618A (en) Mal, a molecular diagnostic marker for hpv-induced invasive cancers and their high-grade precursor lesions
WO2009007958A3 (en) Compositions, methods and kits for the diagnosis of carriers of mutations in the brca1 and brca2 genes and early diagnosis of cancerous disorders associated with mutations in brca1 and brca2 genes
Lin et al. Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
WO2004062487A3 (en) Methods of detecting gene expression in normal and cancerous cells
ATE553112T1 (de) Ttk in der diagnose und als therapeutisches target bei krebs
Chen et al. Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma
HK1126278A1 (en) Identification of non-small cell lung carcinoma (nsclc) tumors expressing pdgfr-alpha pdgfr(nsclc)
ATE545867T1 (de) I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom
Itoga et al. A case of pulmonary hamartoma showing rapid growth
CN108034722A (zh) 一种lncRNA SGOL1-AS1在作为胃癌诊断标志物的应用
Cocieru et al. The role of endoscopic ultrasound and cyst fluid analysis in the initial evaluation and follow-up of incidental pancreatic cystic lesions
WO2005116850A3 (en) Polynucleotides and polypeptides of ovarian cancer
WO2006131783A3 (en) Polynucleotides, polypeptides, and diagnosing lung cancer
EA200701894A1 (ru) Уровень транскрипции гена timp3 в качестве диагностического маркера немелкоклеточного рака легких

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties